In Silico Trials construct hyper-realistic digital patient twins from real-world data, genetic sequencing, and medical imaging to accurately replicate diverse human physiologies and disease progressions. The in silico trials market size is expected to reach US$ 12.75 billion by 2034 from US$ 4.64 billion in 2025. The market is anticipated to register a CAGR of 11.9% during 2026–2034....